Grifols SA (GRFS)
Grifols Market Cap: 6.363B for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.904M |
| Ascendis Pharma A/S | 13.03B |
| NuCana Plc | 14.98M |
| Autolus Therapeutics Plc | 529.63M |
| Mereo BioPharma Group Plc | 66.26M |
Market Cap Related Metrics
| PE Ratio | 15.22 |
| PS Ratio | 0.765 |
| PEG Ratio | 0.0916 |
| Price to Book Value | 2.761 |
| Price to Free Cash Flow | 8.207 |
| Price | 9.35 |
| Earnings Yield | 6.57% |
| PEGY Ratio | 0.0906 |
| Operating PE Ratio | 4.230 |
| Normalized PE Ratio | 16.01 |